Antioxidants Vitamins and Muscle Damage

Sponsor
Universidad Europea de Madrid (Other)
Overall Status
Completed
CT.gov ID
NCT05127928
Collaborator
(none)
18
1
2
24
22.8

Study Details

Study Description

Brief Summary

Determine if acute supplementation with antioxidant vitamins (vitamin C and vitamin E) influences the muscle damage and fatigue caused after an acute session of eccentric training.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Dietary Supplement: Vitamin C and vitamin E
  • Dietary Supplement: Placebo
N/A

Detailed Description

A randomized, single-blind, placebo-control parallel trial will be conducted. In a previous session volunteers will be interviewed to determine if they meet the inclusion criteria.

Participants should avoid ingesting of foods that contain high amounts of antioxidant compounds: more than two juices of fruits, more than four cups of coffee or tea. Juices with high antioxidant content should be avoided. Alcoholic beverages should also be avoided. Participants will be divided in to groups and will performance one resistance exercise sessions. Prior to exercise, one group will intake supplementation VitC (1000 mg) + VitE (235 mg) and the other supplementation with placebo.

The following sequence will be performed in each session: 1) baseline assessment (analysis of the composition body, blood draw and parameters of performance) prior to exercise session ; 2) administration of vitamin or placebo supplementation 2 hours before exercise session ; 3) post-exercise assessments (blood biomarkers and performance parameters) immediately after the session and after 24 hours. DOMS will also be assessed 48 h and 72 h after training. The training session implemented will be designed by a Sport Scientific

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Antioxidants Vitamins and Muscle Damage
Actual Study Start Date :
Feb 10, 2022
Actual Primary Completion Date :
Feb 15, 2022
Actual Study Completion Date :
Mar 6, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Supplementation

Vitamin C and Vitamin E before exercise

Dietary Supplement: Dietary Supplement: Vitamin C and vitamin E
Antioxidant supplementation
Other Names:
  • Ascorbic acid and tocopherol
  • Placebo Comparator: Placebo

    Placebo before exercise

    Dietary Supplement: Placebo
    Placebo administration

    Outcome Measures

    Primary Outcome Measures

    1. Percentage of body fat and muscle mass [Prior to the intervention]

      Determination of body composition using skinfolds measurements

    2. DOMS [0 hours post exercise]

      Delayed onset muscle soreness. This outcome will be measure with a 10-point visual analogic scale (0= no pain; 10 = worst possible pain)

    3. DOMS [24 hours post exercise]

      Delayed onset muscle soreness. This outcome will be measure with a 10-point visual analogic scale (0= no pain; 10 = worst possible pain)

    4. Blood malondialdehyde (MDA) [2 hours prior to exercise]

      MDA will be analyzed from a blood sample

    5. Blood creatine quinase (CK) [2 hours prior to exercise]

      CK will be analyzed from a blood sample

    6. Blood malondialdehyde (MDA) [Inmediatly after exercise]

      MDA will be analyzed from a blood sample

    7. Blood malondialdehyde (MDA) [24 hours after exercise]

      MDA will be analyzed from a blood sample

    8. Blood creatine quinase (CK) [24 hours after exercise]

      CK will be analyzed from a blood sample

    9. Jump height in a Counter Movement Jump [2 hours prior to exercise]

      Jump height (cm) in a counter movement jump measured with Octojump Platform

    10. Jump height in a Counter Movement Jump [Inmediatly after exercise]

      Jump height (cm) in a counter movement jump measured with Octojump Platform

    11. Jump height in a Counter Movement Jump [24 h after exercise]

      Jump height (cm) in a counter movement jump measured with Octojump Platform

    12. Jump Height in a Squat Jump [24 h after exercise]

      Jump Height (cm) in a Squat Jump measured with Octojump Platform

    13. Jump Height in a Squat Jump [Inmediately after exercise]

      Jump Height (cm) in a Squat Jump measured with Octojump Platform

    14. Jump Height in a squat Jump [2 hours prior to exercise]

      Jump height (cm) in a squat jump with Octojump Platform measured with Octojump Platform

    15. Jump Height in a Drop Jump [2 hours prior to exercise]

      Jump height (cm) was measured in different drop jumps with Octojump Platform

    16. Jump Height in a Drop Jump [Inmediately after exercise]

      Jump height (cm) was measured in different drop jumps with Octojump Platform

    17. Contact time in a Drop Jump [Inmediately after exercise]

      Contact time (s)measured in different drop jumps with Octojump Platform

    18. Jump Height in a Drop Jump [Inmediately after exercise]

      Jump height (cm) measured in different drop jumps with Octojump Platform

    19. Contact time in a Drop Jump [24 hours after exercise]

      Contact time (s) measured in different drop jumps with Octojump Platform

    20. Jump Height in a Drop Jump [24 hours after exercise]

      Jump height (cm) measured in different drop jumps with Octojump Platform

    21. Contact time in a Drop Jump [Inmediately after exercise]

      Capillary blood lactate evaluated with Lactate Pro 2

    22. Concentration of blood lactate [2 hours before exercise]

      Capillary blood lactate with Lactate Pro 2

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 33 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy

    • Physically active

    Exclusion Criteria:
    • Injuries

    • Supplementation or drugs

    • Smokers

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Universidad Europea de Madrid Madrid Spain

    Sponsors and Collaborators

    • Universidad Europea de Madrid

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    María Martínez Ferrán, PhD student, principal investigator, Universidad Europea de Madrid
    ClinicalTrials.gov Identifier:
    NCT05127928
    Other Study ID Numbers:
    • CIPI/20/209-part2
    First Posted:
    Nov 19, 2021
    Last Update Posted:
    Apr 7, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by María Martínez Ferrán, PhD student, principal investigator, Universidad Europea de Madrid
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 7, 2022